PubMed دسترسی آزاد

Immunoinformatics-driven design of a multi-epitope vaccine against Clostridium perfringens in yaks.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

INTRODUCTION: Clostridium perfringens is the primary causative agent of enterotoxemia in yaks, resulting in substantial economic losses on the Qinghai-Tibet Plateau. Conventional vaccines exhibit limited protective breadth and suboptimal efficacy, highlighting the need for innovative strategies. Here, we aimed to construct a novel vaccine candidate incorporating epitopes from multiple prevalent toxinotypes (A, C, E) of C. perfringens affecting yaks, using immunoinformatics approach. METHODS: A hierarchical immunoinformatics pipeline was implemented, encompassing subtractive genomics to identify core virulence factors, prediction and filtering of immunogenic T-cell and B-cell epitopes, rational multi-epitope vaccine design incorporating adjuvant and linkers, three-dimensional structure modeling and validation, molecular docking to evaluate interactions with TLR4, molecular dynamics simulations to confirm complex stability, and codon optimization to facilitate heterologous expression. RESULTS AND DISCUSSION: Five core virulence proteins (Iap, CpsE, NanH, Plc, Pfo) were identified from genomic data, leading to the prediction and selection of ten cytotoxic T lymphocyte (CTL) epitopes, five helper T lymphocyte (HTL) epitopes, and five B-cell epitopes. The final 352-amino-acid multi-epitope vaccine (MEV) construct was assembled using the adjuvant human β-defensin-3 and specific linkers (AAY, GPGPG, KK). Computational evaluations confirmed the vaccine's high antigenicity (VaxiJen score: 0.9092), non-allergenic nature, and structural stability. Molecular docking revealed strong binding affinity with TLR2 (-1024.6 kcal/mol) and TLR4 (-1104.4 kcal/mol). Molecular dynamics simulations over 100 ns confirmed stable TLR4 complex with an average RMSD of 0.1971 ± 0.0377 nm, while the TLR2 complex showed an average RMSD of 0.2692 ± 0.0420 nm. Immune simulation profiles predicted the induction of robust humoral and cellular immune responses, including elevated antibody titers, T-cell activation, and cytokine production. In silico cloning verified the potential for efficient expression in E. coli. CONCLUSION: This study designed a novel multi-epitope vaccine against C. perfringens in yaks using an immunoinformatics approach. The vaccine showed high antigenicity, stability, and broad allelic coverage in silico, providing a promising candidate that requires rigorous in vitro and in vivo experimental validation to confirm these computational predictions. This work offers a foundation for the development of effective vaccines against yak C. perfringens infections on the Qinghai-Tibet Plateau.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Clostridium perfringensimmunoinformaticsmolecular dockingmulti-epitope vaccineyak
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Integrative immunoinformatics and structural modeling for the rational design of a multi-epitope vaccine candidate against human cytomegalovirus.

Human cytomegalovirus (CMV) is a globally widespread pathogen associated with significant morbidity in immunocompromised individuals. Despite its clinical importance, no licensed vaccine is currently available. This study aimed to design a rational multi-epitope vaccine candidate targeting CMV using an integrative approach combining immunoinformatics and structural biology. Viral proteins were screened to identify epitopes with high af…

PubMed2026

Shuyu Wan Potentiates PD-1 Inhibitor Efficacy in Non-Small Cell Lung Cancer: Integrated Bioinformatics and Experimental Evidence for Gut Microbiota-Tumor Immune Crosstalk.

BACKGROUND: Therapeutic heterogeneity limits the efficacy of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). Shuyu Wan (SYW), a classic TCM formula, has shown potential in modulating gut microbiota (GM) and enhancing immunotherapy, yet its synergistic mechanism with PD-1 inhibitors remains unclear. MATERIALS AND METHODS: SYW components were identified by UPLC-MS. NSCLC-related targets were integrated with SYW…

PubMed2026

AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition.

BACKGROUND: Neoantigens-tumor-specific peptides generated by somatic mutations-are central targets of effective anticancer T cell immunity and underpin the clinical success of immune checkpoint blockade and personalized cancer vaccines. Advances in high-throughput sequencing, immunopeptidomics, and artificial intelligence (AI) have transformed neoantigen discovery from tailored experimental workflows into scalable, computational pipeli…

PubMed2026

Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology.

Vaccines based on purified antigens, recombinant proteins, and nucleic acid platforms increasingly depend on adjuvants to induce robust, durable, and appropriately polarized immune responses in humans. While classical adjuvants such as aluminum salts and oil-in-water emulsions have enabled the success of many licensed vaccines, their largely empirical design limits adaptability to emerging pathogens and population-specific needs. This …